Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
    source: pixabay.com

    Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient

    Duchenne muscular dystrophy (DMD) is an inherited disease that weakens a child’s muscles and eventually spreads throughout the child’s body. DMD is caused by mutations in the gene that helps…

    Continue Reading Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
    Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
    source: shutterstock.com

    Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease

    Over 100,000 individuals living in the U.S. are on a waiting list for an organ transplant. An average of 17 people die each day while waiting for a donor organ.…

    Continue Reading Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
    Scientists Find Potential Treatment Approach for FTD and ALS
    luvqs / Pixabay

    Scientists Find Potential Treatment Approach for FTD and ALS

    According to a recent article in MedicalXpress, scientists have discovered a possible method of treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The study was also published in Science…

    Continue Reading Scientists Find Potential Treatment Approach for FTD and ALS
    Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
    source: shutterstock.com

    Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World

    Neurological conditions now have the highest rates of disability and ill health worldwide. The Disparity Although more than 80% of the neurological deaths and nervous system disorders occur in lower…

    Continue Reading Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World
    An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination
    source: pixabay.com

    An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination

    For years, scientists have attempted to discover what destroys pneumococcal bacteria after a person has been vaccinated. In a recent study, vaccinologists in the U.S., China, and Switzerland, found the…

    Continue Reading An International Team of Scientists Discovered How Pneumococcal Bacteria is Destroyed After Vaccination
    Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects
    source: pixabay.com

    Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects

    People living with blood disorders like sickle cell disease or thalassemia will now have access to a new blood test that will reduce transfusion side effects. England’s National Health Service…

    Continue Reading Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects
    Huntington’s Disease: Scientists Hope Their Success in Improving Survival in Mice Will Extend to Humans
    source: pixabay.com

    Huntington’s Disease: Scientists Hope Their Success in Improving Survival in Mice Will Extend to Humans

    For years, scientists have been working on a completely new concept that generates new neurons in mice with Huntington's disease. They were able to demonstrate that the new cells could…

    Continue Reading Huntington’s Disease: Scientists Hope Their Success in Improving Survival in Mice Will Extend to Humans
    Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply
    source: shutterstock.com

    Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply

    Out of 103,000 people in the United States waiting for a transplant, almost 88,000 individuals on the waiting list need a kidney transplant. These statistics were recently provided through Organ…

    Continue Reading Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply
    Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study
    source: shutterstock.com

    Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study

    Prilenia Therapeutics, Waltham, Massachusetts and Naarden, Netherlands is a biotechnology company with a focus on developing therapeutics to treat neurodevelopmental disorders and neurodegenerative diseases. Prilenia presented data this month at…

    Continue Reading Prilenia Therapeutics Announces Data Supporting Initiation of Phase III ALS Study
    Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials
    source: shutterstock.com

    Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials

    The primary outcome from the Phase III NETTER-2 clinical trial as reported recently in Globe Newswire, was heralded as extending progression free survival from 8.5 months to 22.8. The participants…

    Continue Reading Encouraging Results in Advanced Gastroenteropancreatic Neuroendocrine Tumors Phase III Trials